CryoPort, Inc. Common Stock (CYRX)

Price$15.99

Value ScoreC

Growth ScoreC

Momentum ScoreA

Favorite Metrics

Price vs S&P 500 (26W)71.52%

Price vs S&P 500 (4W)46.62%

VGM Score65.58

Market Capitalization$790.81M

P/E Ratio (Annual)10.10x

All Metrics

Book Value / Share (Quarterly)$9.86

P/TBV (Annual)1.32x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-9.45%

Cash Flow / Share (Quarterly)$-0.52

Price vs S&P 500 (YTD)52.50%

Gross Margin (TTM)47.19%

Net Profit Margin (TTM)41.57%

EPS (TTM)$1.51

10-Day Avg Trading Volume1.00M

EPS Excl Extra (TTM)$1.51

Revenue Growth (5Y)17.49%

EPS (Annual)$1.56

ROI (Annual)11.35%

Gross Margin (Annual)47.14%

Net Profit Margin (5Y Avg)-37.60%

Cash / Share (Quarterly)$8.04

P/E Basic Excl Extra (TTM)10.40x

Revenue Growth QoQ (YoY)16.47%

P/E Normalized (Annual)10.10x

ROA (Last FY)10.24%

Revenue Growth TTM (YoY)-14.85%

EBITD / Share (TTM)$-0.25

ROE (5Y Avg)-16.59%

Operating Margin (TTM)-21.44%

Cash Flow / Share (Annual)$-0.56

P/B Ratio1.60x

P/B Ratio (Quarterly)0.83x

Net Income / Employee (Annual)$114,500

EV / Revenue (TTM)3.86x

Net Interest Coverage (TTM)-194.57x

ROA (TTM)9.89%

EV / EBITDA (TTM)884.18x

EPS Incl Extra (Annual)$1.56

Current Ratio (Annual)2.17x

Quick Ratio (Quarterly)1.97x

3-Month Avg Trading Volume0.53M

52-Week Price Return163.70%

P/E Incl Extra (TTM)10.40x

Revenue / Employee (TTM)$267,400

Tangible BV / Share (Quarterly)$7.10

P/S Ratio (Annual)4.49x

Asset Turnover (Annual)0.23x

52-Week High$15.85

Operating Margin (5Y Avg)-48.26%

EPS Excl Extra (Annual)$1.56

CapEx CAGR (5Y)15.07%

Tangible BV CAGR (5Y)16.65%

26-Week Price Return87.46%

Quick Ratio (Annual)2.03x

13-Week Price Return83.94%

Total Debt / Equity (Annual)0.37x

Current Ratio (Quarterly)2.09x

Enterprise Value$705.58M

Revenue / Share Growth (5Y)11.53%

Asset Turnover (TTM)0.24x

Book Value / Share Growth (5Y)0.95%

Revenue / Employee (Annual)$257,600

Inventory Turnover (Annual)4.08x

Pretax Margin (Annual)-18.26%

Cash / Share (Annual)$8.25

3-Month Return Std Dev59.91%

Gross Margin (5Y Avg)39.42%

Net Income / Employee (TTM)$111,200

ROE (Last FY)15.58%

Net Interest Coverage (Annual)-16.12x

EPS Basic Excl Extra (Annual)$1.56

Receivables Turnover (TTM)5.43x

Total Debt / Equity (Quarterly)0.38x

EPS Incl Extra (TTM)$1.51

Receivables Turnover (Annual)4.45x

ROI (TTM)10.96%

P/S Ratio (TTM)4.32x

Pretax Margin (5Y Avg)-47.57%

Revenue / Share (Annual)$3.52

Tangible BV / Share (Annual)$7.31

Forward P/E6.12x

Price vs S&P 500 (52W)135.49%

P/E Ratio (TTM)10.40x

Year-to-Date Return63.44%

5-Day Price Return12.07%

EPS Normalized (Annual)$1.56

ROA (5Y Avg)-8.96%

Net Profit Margin (Annual)44.44%

Month-to-Date Return52.92%

Cash Flow / Share (TTM)$-0.59

EBITD / Share (Annual)$-0.18

Operating Margin (Annual)-20.89%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-9.86%

P/E Excl Extra (TTM)10.40x

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$1.51

P/TBV (Quarterly)1.16x

P/B Ratio (Annual)0.96x

Inventory Turnover (TTM)4.29x

Pretax Margin (TTM)-19.13%

Book Value / Share (Annual)$10.08

Price vs S&P 500 (13W)74.19%

Beta1.90x

Revenue / Share (TTM)$3.67

ROE (TTM)15.01%

52-Week Low$5.31

vGradeC

gGradeC

mGradeA

vgmGradeB

Show chart for

Earnings Surprise History

Q1 26-0.25est. -0.22

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

4.27

4.25

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
CYRXCryoPort, Inc. Common Stock	C	C	A	$15.99
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Cryoport is a provider of integrated temperature-controlled logistics and products for the life sciences industry, serving biopharmaceutical, pharmaceutical, animal health, and reproductive medicine markets. The company operates two business segments: Life Sciences Services and Life Sciences Products. With global operations across the Americas, Europe, the Middle East, Africa, and Asia Pacific, Cryoport generates the majority of its revenue from North American operations.